[1]薄 龙.顺铂热化疗灌注联合肝动脉灌注化疗栓塞术治疗肝癌的远期疗效及对肿瘤细胞因子水平的影响[J].医学信息,2022,35(04):121-123.[doi:10.3969/j.issn.1006-1959.2022.04.030]
　BO Long.Long-term Efficacy of Cisplatin Thermochemotherapy Perfusion Combined with Transcatheter Arterial Chemoembolization in the Treatment of Liver Cancer and its Effect on Tumor Cytokine Levels[J].Medical Information,2022,35(04):121-123.[doi:10.3969/j.issn.1006-1959.2022.04.030]
点击复制

顺铂热化疗灌注联合肝动脉灌注化疗栓塞术治疗肝癌的远期疗效及对肿瘤细胞因子水平的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年04期
页码:
121-123
栏目:
论著
出版日期:
2022-02-15

文章信息/Info

Title:
Long-term Efficacy of Cisplatin Thermochemotherapy Perfusion Combined with Transcatheter Arterial Chemoembolization in the Treatment of Liver Cancer and its Effect on Tumor Cytokine Levels
文章编号:
1006-1959（2022）04-0121-03
作者:
薄 龙
阜新市中心医院介入血管<神经>外科，辽宁 阜新 123000
Author(s):
BO Long
Department of Interventional Vascular Neurosurgery,Fuxin Central Hospital,Fuxin 123000,Liaoning,China
关键词:
肝癌; 顺铂热化疗灌注; 肝动脉灌注化疗栓塞术; 肿瘤细胞因子
Keywords:
Liver cancer; Cisplatin thermochemotherapy infusion; Transcatheter arterial chemoembolization; Tumor cytokines
分类号:
R734.2
DOI:
10.3969/j.issn.1006-1959.2022.04.030
文献标志码:
A
摘要:
目的 探究顺铂热化疗灌注联合肝动脉灌注化疗栓塞术（TACE）对肝癌患者远期疗效及肿瘤相关细胞因子的影响。方法 选取2018年5月-2020年5月我院收治的80例肝癌患者作为研究对象，采用随机数字表法分为对照组和观察组，每组40例。对照组采用TACE治疗，观察组采用顺铂热化疗灌注联合TACE治疗，比较两组近期疗效、术后不良反应、肿瘤相关细胞因子指标（VEGF、HIF-2α、sIL-2R）、远期疗效。结果 观察组客观缓解率为80.00%，高于对照组的57.50%，差异有统计学意义（P＜0.05）；两组肠胃道反应、骨髓抑制、皮疹、转氨酶升高的发生率比较，差异无统计学意义（P＞0.05）；观察组VEGF、HIF-2α、sIL-2R水平低于对照组，差异有统计学意义（P＜0.05）；随访1年后，观察组复发率低于对照组，总生存率高于对照组，无进展生存时间长于对照组，差异有统计学意义（P＜0.05）。结论 顺铂热化疗灌注联合TACE可提升肝癌患者的肿瘤控制效果，进一步降低肿瘤相关细胞因子水平的表达，且不增加不良反应发生几率，远期疗效理想。
Abstract:
Objective To explore the effects of cisplatin thermochemotherapy combined with transcatheter arterial chemoembolization(TACE) on the long-term efficacy and tumor-related cytokines in patients with liver cancer.Methods A total of 80 patients with liver cancer admitted to our hospital from May 2018 to May 2020 were selected as subjects. They were divided into control group and observation group by random number table method, with 40 cases in each group. The control group was treated with TACE, and the observation group was treated with cisplatin thermochemotherapy perfusion combined with TACE. The short-term efficacy, postoperative adverse reactions, tumor related cytokine indexes (VEGF, HIF-2α, sIL-2R) and long-term efficacy were compared between the two groups.Results The objective remission rate of the observation group was 80.00%, which was higher than 57.50% of the control group, and the difference was statistically significant (P<0.05). There was no significant difference in the incidence of gastrointestinal tract reaction, bone marrow suppression, rash and elevated transaminase between the two groups (P>0.05).The levels of VEGF, HIF-2α and sIL-2R in the observation group were lower than those in the control group, and the difference was statistically significant (P<0.05). After 1 year of follow-up, the recurrence rate of the observation group was lower than that of the control group, the overall survival rate was higher than that of the control group, and the progression-free survival time was longer than that of the control group, the difference was statistically significant (P<0.05).Conclusion Cisplatin thermochemotherapy perfusion combined with TACE can improve the tumor control effect of liver cancer patients, further reduce the expression of tumor related cytokines, and does not increase the probability of adverse reactions, and the long-term curative effect is ideal.

参考文献/References:

[1]吴铮,王健,张金辉,等.肝癌肝动脉化疗栓塞介入术后感染影响因素及其血清PCT与CRP和IL-8水平[J].中华医院感染学杂志,2021,31(3):409-412.[2]何泳铸,何坤,王泽亮,等.腹腔热灌注化疗在肝癌破裂出血术后肿瘤复发中的应用价值[J].中华肝胆外科杂志,2020,26(6):431-434.[3]张浩,仲富瑞,程宦立,等.肝动脉灌注化疗栓塞联合射频消融治疗中晚期肝癌的疗效分析[J].中国普通外科杂志,2020,29(1):35-42.[4]张萍,艾斌.实体瘤免疫治疗疗效评价标准[J].国际肿瘤学杂志,2016,43(11):848-851.[5]唐启耀,尹君.原发性肝癌切除术后行肝动脉化疗栓塞术与化疗灌注术的疗效观察[J].现代肿瘤医学,2019,27(19):3475-3479.[6]朱鸷翔,沈松鹤,赵森,等.中晚期原发性肝癌TACE介入微创治疗的疗效和对肝功能的影响[J].黑龙江医学,2020,44(11):1483-1485. [7]杨晓倩,孟宪萌.TACE治疗肝癌的效果观察及对患者AFP、miR-202和VEGF的影响分析[J].河北医药,2019,41(6):870-873.[8]刘亚,曾建挺,张艳林,等.灌注式热化疗联合微球在原发性肝癌介入治疗中的价值[J].中国医学物理学杂志,2018,35(11):1339-1344.[9]罗红兰,刘凯,朱晓东,等.肝动脉灌注化疗栓塞术治疗原发性肝癌120例肝功能损伤分析[J].安徽医药,2018,22(7):1366-1368.[10]吴晓邡,孟秋丽,万绍贵.替吉奥联合肝动脉灌注化疗栓塞术治疗中晚期肝细胞癌临床分析[J].中华实用诊断与治疗杂志,2018,32(2):179-181.[11]Wang Y,Ma L,Sheng S,et al.Combination therapy of TACE and CT-guided partial hepatic segment ablation for liver cancer[J].Minim Invasive Ther Allied Technol,2018,27(6):355-364. [12]杨红茹,范娟,刘端.顺铂序贯恩度胸腔热灌注治疗晚期肺癌恶性胸腔积液的疗效观察[J].泸州医学院学报,2016,39(5):461-464.[13]杜锋,杨炜炜,刘尧.顺铂热化疗灌注联合TACE对肝癌患者疗效及肿瘤细胞因子水平的影响[J].贵州医药,2021,45(1):27-28.[14]林洁.持续腹腔热灌注化疗对肝癌晚期患者肿瘤标记物CA199、AFP及CEA的影响[J].中国医药科学,2016,6(11):226-228.[15]武中林,李智岗,吴晓云,等.经导管肝动脉栓塞与肝动脉灌注化疗栓塞在原发性肝癌介入治疗中的远期疗效比较[J].中国全科医学,2016,19(11):1292-1296.[16]李国平,刘丽璇,蒲泽锦,等.慢病毒介导HIF-1α沉默对缺氧肝癌细胞HepG2增殖和凋亡的影响[J].武汉大学学报(医学版),2019,40(1):27-32,104.

相似文献/References:

[1]修朋程,李 腾,李雅林,等.泰山山慈菇对小鼠肝癌的治疗作用及相关免疫机制研究[J].医学信息,2018,31(09):8.[doi:10.3969/j.issn.1006-1959.2018.09.003]
　XIU Peng-cheng,LI Teng,LI Ya-lin,et al.Study on the Therapeutic Effect and Mechanism of Taishan Mountain Mushroom on Liver Cancer in Mice[J].Medical Information,2018,31(04):8.[doi:10.3969/j.issn.1006-1959.2018.09.003]
[2]崔康健,杜成友.肝动脉化疗栓塞联合射频消融治疗肝癌的研究进展[J].医学信息,2018,31(09):16.[doi:10.3969/j.issn.1006-1959.2018.09.005]
　CUI Kang-jian,DU Cheng-you.Research Progress of Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation for Liver Cancer[J].Medical Information,2018,31(04):16.[doi:10.3969/j.issn.1006-1959.2018.09.005]
[3]田 明,常伟平.UbcH10在肝癌中的表达及其与预后的关系[J].医学信息,2019,32(12):77.[doi:10.3969/j.issn.1006-1959.2019.12.024]
　IAN Ming,CHANG Wei-ping.Expression of UbcH10 in Hepatocellular Carcinoma and Its Relationship with Prognosis[J].Medical Information,2019,32(04):77.[doi:10.3969/j.issn.1006-1959.2019.12.024]
[4]许 吉.基于知识图谱和专利地图的我国抗肝癌药物研发态势研究[J].医学信息,2018,31(21):19.[doi:10.3969/j.issn.1006-1959.2018.21.007]
　XU Ji.Research and Development Situation of Anti-liver Cancer Drugs in China Based on Knowledge Map and Patent Map[J].Medical Information,2018,31(04):19.[doi:10.3969/j.issn.1006-1959.2018.21.007]
[5]兰福全,李秀云,卢 斌.四种肿瘤标志物对肝癌诊断的临床意义[J].医学信息,2018,31(21):164.[doi:10.3969/j.issn.1006-1959.2018.21.048]
　LAN Fu-quan,LI Xiu-yun,LU Bin.The Clinical Significance of Four Tumor Markers in the Diagnosis of Liver Cancer[J].Medical Information,2018,31(04):164.[doi:10.3969/j.issn.1006-1959.2018.21.048]
[6]李 闯,叶劲松,刘 昕,等.ZBP-89与缺氧信号因子HIF-1α在肝癌细胞中的 相关性研究[J].医学信息,2019,32(15):74.[doi:10.3969/j.issn.1006-1959.2019.15.023]
　LI Chuang,YE Jin-song,LIU Xin,et al.Correlation between ZBP-89 and Hypoxia Signaling Factor HIF-1α in Hepatoma Cells[J].Medical Information,2019,32(04):74.[doi:10.3969/j.issn.1006-1959.2019.15.023]
[7]赵瑶瑶,高 川,胡佳杰.循环miRNA监测肝细癌的研究[J].医学信息,2019,32(08):48.[doi:10.3969/j.issn.1006-1959.2019.08.016]
　ZHAO Yao-yao,GAO Chuan,HU Jia-jie.Research on the Study of Circulating miRNA for Monitoring Hepatocellular Carcinoma[J].Medical Information,2019,32(04):48.[doi:10.3969/j.issn.1006-1959.2019.08.016]
[8]孙 逊.性化护理对肝癌患者CT引导下射频消融术后 负性情绪及生活质量的影响[J].医学信息,2019,32(17):187.[doi:10.3969/j.issn.1006-1959.2019.17.065]
　SUN Xun.Effect of Humanized Nursing on Negative Emotion and Quality of Life after CT-guided Radiofrequency Ablation in Patients with Liver Cancer[J].Medical Information,2019,32(04):187.[doi:10.3969/j.issn.1006-1959.2019.17.065]
[9]徐 蓓,魏霞丽,常艳琴.肝癌患者术后自我饮食管理体验的质性研究[J].医学信息,2019,32(20):180.[doi:10.3969/j.issn.1006-1959.2019.20.058]
　XU Bei,WEI Xia-li,CHANG Yan-qin.Qualitative Study of Postoperative Self-Catering Management Experience in Patients with Liver Cancer[J].Medical Information,2019,32(04):180.[doi:10.3969/j.issn.1006-1959.2019.20.058]
[10]刘申颖,施彦卿,梅鹏飞,等.超声引导下经皮无水乙醇注射联合射频消融治疗中晚期肝癌的效果[J].医学信息,2019,32(22):87.[doi:10.3969/j.issn.1006-1959.2019.22.026]
　LIU Shen-ying,SHI Yan-qing,MEI Peng-fei,et al.Ultrasound-guided Percutaneous Ethanol Injection Combined with Radiofrequency Ablation for Advanced Hepatocellular Carcinoma[J].Medical Information,2019,32(04):87.[doi:10.3969/j.issn.1006-1959.2019.22.026]

更新日期/Last Update: 1900-01-01